Clinical Trial Update: Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase II, single-arm study of AZD1775 monotherapy in relapsed small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• AZD1775 (Adavosertib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED